Mirae Asset Healthcare Fund - Growth - Regular Plan

  • Previous Nav

  • Net Change on 11-12-2019

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Growth | Regular Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

The investment objective of the scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies benefitting directly or indirectly in Healthcare and allied sectors in India. The Scheme does not guarantee or assure any returns.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
S&P BSE Health Care - TRI 1.20 1.77 -2.36 -4.49 -1.72 11.56
S&P BSE SENSEX - TRI 0.17 8.55 16.30 16.12 9.35 13.18

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
Nippon India Pharma Fund-Growth Plan-Growth Jun 05, 2004 Unrated 0.87 1.74 3.55 2.13 2,434.45
UTI Healthcare Fund - Regular Plan - Growth Option Aug 01, 2005 Unrated 1.99 -2.31 -0.32 2.52 400.93

Fund Holdings as on 30-November-2019

  • Sun Pharmaceutical Industries Limited

  • Divi's Laboratories Limited

  • Dr. Reddy's Laboratories Limited

  • IPCA Laboratories Limited

  • Cipla Limited

  • Biocon Limited

  • Torrent Pharmaceuticals Limited

  • Dr. Lal Path Labs Limited

  • Lupin Limited

  • Ajanta Pharma Limited

  • Syngene International Limited

  • Alkem Laboratories Limited

  • Vinati Organics Limited

  • Tri Party Repo

  • Sanofi India Limited

  • Laurus Labs Limited

  • Neogen Chemicals Limited

  • Navin Fluorine International Limited

  • Aurobindo Pharma Limited

  • Max Financial Services Limited

  • Tata Chemicals Limited

  • Jubilant Life Sciences Limited

  • Natco Pharma Limited

  • Net Receivables / (Payables)

  • Abbott India Limited

  • Cadila Healthcare Limited

  • Mirae Asset Cash Management Fund - DIRECT GROWTH

View More
  • Pharmaceuticals & Drugs

  • Chemicals

  • Hospital & Healthcare Services

  • Miscellaneous

  • Finance - Others

View More

About Mirae Asset Healthcare Fund

Scheme Analysis

Mirae Asset Healthcare Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to Mirae Asset Mutual Fund. It was launched on 02-Jul-2018 and currently has an AUM of ₹366.65 crore. Mirae Asset Healthcare Fund is benchmarked against S&P BSE Health Care - TRI as primary index and S&P BSE SENSEX - TRI as secondary index.

The NAV of Mirae Asset Healthcare Fund ended up ₹0.07(0.69%)yesterday to ₹10.75.

Among its top 3 holdings the fund has exposure to Sun Pharmaceutical Industries Limited, Divi's Laboratories Limited and Dr. Reddy's Laboratories Limited

The Mirae Asset Healthcare Fund is managed by Vrijesh Kasera .

Fund House Contact

Unit 606, 6th Floor, Windsor, Off CST Road, Kalina, Santacruz (E), Mumbai - 400 098

022-67800300
022-67253942

Fund Manager

  • Cash

  • Equity

  • MFU

View More